Anne Morgan Giroux is pretty sure the cure for epilepsy ‒ or at least a long-term solution for millions ‒ is sitting in a university lab in Madison, Wisconsin. She and a team of researchers need just $3.3 million to push it across the finish line.
The problem: That $3.3 million solution is on indefinite hold as President Donald Trump and his administration slashes government spending. The money would have been awarded as grants from the National Institutes of Health to launch human trials. Epilepsy affects about 1% of U.S. adults, or around 3 million people.